H1B Report
Side-by-side comparison

Aurolife Pharma LLC vs COGNIZANT TECHNOLOGY SOLUTIONS US CORP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Aurolife Pharma LLC
NJRank #FEIN 26-2273768
Entity B
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAurolife Pharma LLCCOGNIZANT TECHNOLOGY SOLUTIONS US CORP
Total filings69128,852
Certified %97.10%96.13%
Denied %1.45%0.28%
Withdrawn %1.45%2.23%
Cert-withdrawn %0.00%1.36%
Rank#2
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJTX

Outcomes — Aurolife Pharma LLC

DOL case-status mix.

Outcome breakdown: Certified 97.1%, Withdrawn 1.4%, Denied 1.4%
Outcome breakdown
OutcomeShare
Certified97.1%
Withdrawn1.4%
Denied1.4%
Certified97.1%
Withdrawn1.4%
Denied1.4%

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Aurolife Pharma LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103
FY20113
FY20127
FY20135
FY20142
FY20152
FY20164
FY20177
FY20186
FY20194
FY20201
FY20218
FY20220
FY20230
FY20248
FY20253
FY20266
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.